It showed decreased activity in the PPAR signaling pathway and glycerolipid metabolism, and increased activity in the Jak-STAT signaling pathway, leukocyte migration, chemokine signaling, and cytokine interactions in sarcopenia samples (Figure 14D). The gene discussed is PPARA; the disease is sarcopenia.